UniProt ID | FBLN1_HUMAN | |
---|---|---|
UniProt AC | P23142 | |
Protein Name | Fibulin-1 | |
Gene Name | FBLN1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 703 | |
Subcellular Localization | Secreted, extracellular space, extracellular matrix. | |
Protein Description | Incorporated into fibronectin-containing matrix fibers. May play a role in cell adhesion and migration along protein fibers within the extracellular matrix (ECM). Could be important for certain developmental processes and contribute to the supramolecular organization of ECM architecture, in particular to those of basement membranes. Has been implicated in a role in cellular transformation and tumor invasion, it appears to be a tumor suppressor. May play a role in haemostasis and thrombosis owing to its ability to bind fibrinogen and incorporate into clots. Could play a significant role in modulating the neurotrophic activities of APP, particularly soluble APP.. | |
Protein Sequence | MERAAPSRRVPLPLLLLGGLALLAAGVDADVLLEACCADGHRMATHQKDCSLPYATESKECRMVQEQCCHSQLEELHCATGISLANEQDRCATPHGDNASLEATFVKRCCHCCLLGRAAQAQGQSCEYSLMVGYQCGQVFQACCVKSQETGDLDVGGLQETDKIIEVEEEQEDPYLNDRCRGGGPCKQQCRDTGDEVVCSCFVGYQLLSDGVSCEDVNECITGSHSCRLGESCINTVGSFRCQRDSSCGTGYELTEDNSCKDIDECESGIHNCLPDFICQNTLGSFRCRPKLQCKSGFIQDALGNCIDINECLSISAPCPIGHTCINTEGSYTCQKNVPNCGRGYHLNEEGTRCVDVDECAPPAEPCGKGHRCVNSPGSFRCECKTGYYFDGISRMCVDVNECQRYPGRLCGHKCENTLGSYLCSCSVGFRLSVDGRSCEDINECSSSPCSQECANVYGSYQCYCRRGYQLSDVDGVTCEDIDECALPTGGHICSYRCINIPGSFQCSCPSSGYRLAPNGRNCQDIDECVTGIHNCSINETCFNIQGGFRCLAFECPENYRRSAATLQQEKTDTVRCIKSCRPNDVTCVFDPVHTISHTVISLPTFREFTRPEEIIFLRAITPPHPASQANIIFDITEGNLRDSFDIIKRYMDGMTVGVVRQVRPIVGPFHAVLKLEMNYVVGGVVSHRNVVNVHIFVSEYWF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
45 | Phosphorylation | ADGHRMATHQKDCSL CCCCHHHCCCCCCCC | 18.59 | - | |
48 | Acetylation | HRMATHQKDCSLPYA CHHHCCCCCCCCCCC | 53.77 | 19816763 | |
56 | Phosphorylation | DCSLPYATESKECRM CCCCCCCCCCHHHHH | 34.64 | 27251275 | |
56 | O-linked_Glycosylation | DCSLPYATESKECRM CCCCCCCCCCHHHHH | 34.64 | OGP | |
58 | Phosphorylation | SLPYATESKECRMVQ CCCCCCCCHHHHHHH | 29.42 | 24719451 | |
59 | Ubiquitination | LPYATESKECRMVQE CCCCCCCHHHHHHHH | 55.38 | - | |
98 | N-linked_Glycosylation | CATPHGDNASLEATF CCCCCCCCCHHHHHH | 35.70 | 17623646 | |
98 | N-linked_Glycosylation | CATPHGDNASLEATF CCCCCCCCCHHHHHH | 35.70 | 17623646 | |
100 | Phosphorylation | TPHGDNASLEATFVK CCCCCCCHHHHHHHH | 32.75 | 27251275 | |
147 | Phosphorylation | FQACCVKSQETGDLD EHHHEECCCCCCCCC | 16.92 | 26657352 | |
150 | Phosphorylation | CCVKSQETGDLDVGG HEECCCCCCCCCCCC | 28.49 | 26657352 | |
163 | Ubiquitination | GGLQETDKIIEVEEE CCCEECCEEEEEEEH | 53.67 | - | |
175 | Phosphorylation | EEEQEDPYLNDRCRG EEHHCCCCCCCCCCC | 30.38 | - | |
246 | Phosphorylation | SFRCQRDSSCGTGYE EEEEECCCCCCCCCE | 29.71 | 27251275 | |
247 | Phosphorylation | FRCQRDSSCGTGYEL EEEECCCCCCCCCEE | 22.36 | 28348404 | |
250 | Phosphorylation | QRDSSCGTGYELTED ECCCCCCCCCEECCC | 40.70 | 22798277 | |
252 | Phosphorylation | DSSCGTGYELTEDNS CCCCCCCCEECCCCC | 13.96 | 22985185 | |
285 | Phosphorylation | ICQNTLGSFRCRPKL HHCCCCCCCCCCCCC | 16.78 | 24719451 | |
369 | Ubiquitination | PPAEPCGKGHRCVNS CCCCCCCCCCCCCCC | 59.26 | - | |
433 | Phosphorylation | CSVGFRLSVDGRSCE CEEEEEEEECCCCCC | 17.57 | 24719451 | |
489 | O-linked_Glycosylation | IDECALPTGGHICSY CCCCCCCCCCEEECE | 57.56 | OGP | |
535 | N-linked_Glycosylation | ECVTGIHNCSINETC HHHCCCCCCCCCCEE | 21.22 | UniProtKB CARBOHYD | |
539 | N-linked_Glycosylation | GIHNCSINETCFNIQ CCCCCCCCCEEEEEC | 23.41 | UniProtKB CARBOHYD | |
563 | Phosphorylation | CPENYRRSAATLQQE CCCHHHHHCHHHHHH | 17.16 | 24719451 | |
563 (in isoform 3) | Phosphorylation | - | 17.16 | 24719451 | |
566 | Phosphorylation | NYRRSAATLQQEKTD HHHHHCHHHHHHHCC | 25.47 | 24719451 | |
566 (in isoform 3) | Phosphorylation | - | 25.47 | 24719451 | |
609 (in isoform 4) | Phosphorylation | - | 6.47 | - | |
611 | Methylation | PTFREFTRPEEIIFL CCHHHCCCCHHEEEE | 41.79 | - | |
631 (in isoform 4) | Phosphorylation | - | 21.91 | - | |
632 (in isoform 4) | Phosphorylation | - | 3.58 | - | |
651 | Phosphorylation | SFDIIKRYMDGMTVG HHHHHHHHCCCCCEE | 8.44 | - | |
656 | Phosphorylation | KRYMDGMTVGVVRQV HHHCCCCCEEEEEEC | 21.45 | - | |
680 (in isoform 4) | Phosphorylation | - | 8.66 | 28634120 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBLN1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBLN1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBLN1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 11238726 | |
NID1_HUMAN | NID1 | physical | 9299350 | |
NID1_HUMAN | NID1 | physical | 9278415 | |
FBLN1_HUMAN | FBLN1 | physical | 9278415 | |
FIBB_HUMAN | FGB | physical | 7642629 | |
NOV_HUMAN | NOV | physical | 9927660 | |
CTGF_HUMAN | CTGF | physical | 9927660 | |
TF7L2_HUMAN | TCF7L2 | physical | 21988832 | |
TAF9_HUMAN | TAF9 | physical | 21988832 | |
FINC_HUMAN | FN1 | physical | 21988832 | |
SMAD3_HUMAN | SMAD3 | physical | 21988832 | |
NOTC3_HUMAN | NOTCH3 | physical | 21988832 | |
PLS1_HUMAN | PLSCR1 | physical | 21988832 | |
TDGF1_HUMAN | TDGF1 | physical | 21988832 | |
LTBP4_HUMAN | LTBP4 | physical | 21988832 | |
TANK_HUMAN | TANK | physical | 21988832 | |
1433T_HUMAN | YWHAQ | physical | 21988832 | |
NEDD1_HUMAN | NEDD1 | physical | 21988832 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...